Related Experiment Video
Updated: Jul 14, 2026
05:00
Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt
Published on: August 23, 2024
The difficulties of a randomized study in superior vena caval obstruction
Paula Wilson1, Andrea Bezjak, Murray Asch
1Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada.
Summary
Recruiting patients for a randomized trial comparing superior vena cava stenting versus radiation therapy for malignant superior vena caval obstruction proved challenging. The study encountered significant accrual difficulties, highlighting potential barriers to clinical trial participation in this patient population.
Area of Science:
- Oncology
- Interventional Radiology
- Clinical Trials
Background:
- Superior vena caval obstruction (SVCO) is a frequent complication of advanced cancer.
- Current treatments include radiation therapy (RT), chemotherapy, and supportive care.
- Expandable stents offer rapid symptom relief for SVCO, but randomized data are lacking.
Purpose of the Study:
- To compare symptom response between palliative radiation therapy and immediate superior vena cava stenting followed by radiation.
- To assess symptom response and outcomes in patients with malignant SVCO regardless of treatment arm.
Main Methods:
- A randomized study was designed to compare palliative RT versus immediate SVC stenting followed by RT.
- A prospective longitudinal study was established to gather data on symptom response and outcomes.
- The randomized study aimed to randomize patients to one of the two treatment arms.
Main Results:
- The randomized study failed to accrue any patients over a 12-month period.
- Of 19 patients approached, 13 enrolled in the parallel longitudinal study.
- Significant challenges were encountered in patient recruitment for the randomized trial.
Conclusions:
- The study encountered significant difficulties in patient accrual for the randomized trial.
- These findings highlight potential barriers to conducting randomized trials for SVCO.
- Further investigation is needed to understand and overcome recruitment challenges in this patient group.
